Dasit SPA

Dasit SPA, an Italian for-profit medical equipment and consumables supplier based in Milan, operates exclusively as a prime contractor (100% of recent awards) providing Sysmex hematology and coagulation analyzer supplies, reagents, maintenance services, and equipment leasing to the U.S. Department of Defense. The vendor competes entirely under full-and-open competition with no set-aside designations and has been registered in the System for Award Management since May 2012.

Dasit SPA's customer footprint is highly concentrated in Navy Medicine. The Department of the Navy Bureau of Medicine and Surgery accounts for 76 awards (57% of total awards) with $2.9 million in combined potential value, while the Defense Health Agency holds 53 awards (40%) valued at $1.1 million combined; these two customers represent 100% of the vendor's recent award activity. The remaining two customers—the Department of the Navy Naval Supply Systems Command and the Department of the Navy Installations Command—account for four awards totaling $614 thousand. Work is performed in Italy, primarily supporting U.S. Naval Hospital Sigonella and other forward-deployed military medical treatment facilities.

Dasit SPA holds five parent indefinite delivery contracts anchoring its federal footprint. The largest vehicles by task-order count are Indefinite Delivery Contract N6817119D2004 (28 task orders, $231 thousand combined potential value) and Indefinite Delivery Contract N6817123D2007 (28 task orders, $223 thousand combined potential value), both supporting supplies and consumables for Sysmex equipment. Contracts N6817114D0022, N6817121D0040, and N6817118D0010 carry combined potential values of $375 thousand, $441 thousand, and $367 thousand respectively, with five to six task orders each. The vendor's primary single-award IDV from the Defense Health Agency, valued at $249,999 and expiring September 21, 2026, supplies Sysmex medical diagnostic equipment consumables to Navy Medicine facilities.

Recent capability work spans supplies procurement, equipment maintenance, analyzer leasing, and technical assistance. Representative prime awards include a $44,764.90 purchase order from the Defense Health Agency (March 2025) for technical assistance on a coagulation system with an option exercise extending through February 2030; a $142,841.92 order (June 2023) for hematology analyzers and associated consumables and maintenance services; a $100,424.91 lease arrangement (January 2023) for coagulation analyzer equipment through December 2025; and a $94,514.80 delivery order from the Bureau of Medicine and Surgery (July 2023) for supplies and maintenance services running through June 2024. Delivery orders typically range from several hundred dollars to roughly $30,000, with performance periods of one to three months for consumables and extended periods for equipment leases and technical support contracts.

Activity has remained steady at approximately 12 awards per year from 2022 through 2025, with three awards recorded to date in 2026. Dasit SPA holds $4.5 million in combined potential value across all 133 awards in the source data, with $2.7 million (59%) obligated to date. The vendor's award history extends from June 2008 through March 2026, establishing a consistent supplier relationship with Navy Medicine spanning roughly fourteen years. Dasit SPA's capability portfolio centers exclusively on Sysmex diagnostic equipment—specifically hematology and coagulation analyzers—and includes consumables, reagents, maintenance services, equipment leasing, and technical support, with no work recorded outside the military medical laboratory space.